George Uveges

George Uveges is a declared insider at 2 companies; the most frequent names are Harvard Bioscience Inc and Mfic Corp. Over a trading history stretching from 19 November 2007 to 14 March 2018, the count stands at 44 filings.

In open-market terms, that means 19 purchases worth €53k on one side and 2 sales worth €212k on the other. Sales outweigh purchases by €159k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 15 share grants and 6 option exercises. 2018 to date brings no purchases and 2 sales.

In size, the median ticket on the buying side is €1,975. Looking at 11 purchases old enough to measure, the stock rose over the following 90 days in 82% of cases; the median change was +4.0%. Past outcomes like these are no guarantee of what comes next.

On 15 March 2018 came the latest disclosure, an option exercise for €18k in Harvard Bioscience Inc. The latest purchase dates back some time: it was published 3,993 days ago, on 3 December 2015. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.